102 results
Page 2 of 6
S-8
EX-99.3
auzkvhm4f3ps rmhu
14 Jan 22
Registration of securities for employees
5:04pm
8-K
EX-99.2
nykae kpus032
15 Nov 21
Regulation FD Disclosure
11:32am
424B5
4h031gcoova
12 Nov 21
Prospectus supplement for primary offering
4:09pm
8-K
4n18q8egw9wwz89
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-1.1
6azku5a24o06 e8d4
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
EX-99.1
8o8g5y
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
5vzp8n
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
gci08ao
17 Mar 21
Prospectus supplement for primary offering
5:07pm
8-K
av6 tptqu
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am